Elspar
Term · Oncology and biomedicine · MLC-T-ONC-002756
A drug that is used to treat acute lymphoblastic leukemia (ALL) and is being studied in the treatment of some other types of cancer. It is an enzyme taken from the bacterium Escherichia coli (E. coli). It breaks down the amino acid asparagine and may block the growth of tumor cells that need asparagine to grow. Also called asparaginase and L-asparaginase.
| Identifier | MLC-T-ONC-002756 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | asparaginase; L-asparaginase |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002756",
"term": "Elspar",
"field": "Oncology and biomedicine",
"definition": "A drug that is used to treat acute lymphoblastic leukemia (ALL) and is being studied in the treatment of some other types of cancer. It is an enzyme taken from the bacterium Escherichia coli (E. coli). It breaks down the amino acid asparagine and may block the growth of tumor cells that need asparagine to grow. Also called asparaginase and L-asparaginase.",
"synonyms": [
"asparaginase",
"L-asparaginase"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/elspar/"
}
Record 6,560 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.